Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Diagnostic Approach

  • The British Society of Gastroenterology recommends testing rather than empirical treatment to improve antibiotic stewardship and avoid treating patients who don't actually have SIBO 1
  • Combined hydrogen and methane breath testing is more accurate than hydrogen-only testing for identifying SIBO 1, 2
  • Glucose or lactulose breath tests should be used when available 1
  • Qualitative small bowel aspiration during upper endoscopy is an alternative when breath testing is unavailable 1

First-Line Antibiotic Treatment

  • Rifaximin 550 mg twice daily for 1-2 weeks is the first-line treatment for proven SIBO, achieving 60-80% efficacy in eradicating bacterial overgrowth 1, 2
  • Rifaximin is preferred because it reduces systemic resistance risk 1, 2
  • Effective for both hydrogen-dominant and methane-dominant SIBO 1
  • Doxycycline, Ciprofloxacin, Amoxicillin-clavulanic acid, and Cefoxitin are equally effective alternatives 1, 2
  • Metronidazole should be avoided as first-line treatment due to documented lower efficacy 1, 2

Management of Recurrent SIBO

  • For patients with recurrent SIBO, use one of the following strategies: cyclical antibiotics, low-dose long-term antibiotics, or recurrent short courses of antibiotics 1, 2
  • Patients with reversible causes typically need only one antibiotic course, while those with persistent underlying causes require ongoing management strategies 1

Adjunctive Dietary Management

  • A low-FODMAP diet for 2-4 weeks reduces fermentable carbohydrates that feed bacterial overgrowth, although this citation is from a less preferred source 5
  • Adequate protein intake while reducing fat consumption minimizes steatorrhea, although this citation is from a less preferred source 5
  • Complex carbohydrates and fiber from non-cereal plant sources support gut motility, although this citation is from a less preferred source 5, 4

Monitoring for Complications

  • Monitor for nutritional deficiencies, including fat-soluble vitamins (A, D, E, K), vitamin B12, and iron 5
  • Vitamin D deficiency occurs in 20% of patients if bile acid sequestrants are needed 1
  • Consider bile salt sequestrants (cholestyramine or colesevelam) for persistent steatorrhea, starting at low doses and titrating slowly 1, 5
  • Monitor closely for worsening vitamin deficiencies when using bile salt sequestrants 1, 5

Special Considerations for Methane-Dominant SIBO

  • Rifaximin remains first-line treatment for methane-dominant SIBO, although this citation is from a less preferred source 4
  • Combination therapy (antibiotics plus probiotics after treatment) may be effective, although this citation is from a less preferred source 4